Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla (Q57575185)

3

0 references

Michael Weber

object named as

Michael Weber

8

0 references

Benjamin S. Halpern

4

object named as

Benjamin S. Halpern

0 references

author name string

Julia Fruehwald-Pallamar

1

0 references

Christian Czerny

2

0 references

Christina Eder-Czembirek

5

0 references

Matthias Schuetz

7

0 references

Laura Fruehwald

9

0 references

Andreas M. Herneth

10

0 references

publication date

5 April 2011

0 references

number of pages

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

0 references

volume

38

0 references

issue

6

0 references

page(s)

1009-1019

0 references

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Imaging of the larynx and hypopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Oral and oropharyngeal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

PET/CT in head and neck cancer: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Theoretical Model for Water Diffusion in Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Role of diffusion-weighted MR imaging in cervical lymphadenopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Additional diagnostic value of (18)F-FDG PET-CT in detecting retropharyngeal nodal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Basic principles of diffusion-weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Tissue characterization of head and neck lesions using diffusion-weighted MR imaging with SPLICE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Role of diffusion weighted MR in the discrimination diagnosis of the cystic and/or necrotic head and neck lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Initial experience of 3-tesla apparent diffusion coefficient values in characterizing squamous cell carcinomas of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Diffusion-weighted imaging in head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Diffusion-weighted MRI for assessment of early cancer treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Posttreatment imaging in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

Role of Diffusion-Weighted Magnetic Resonance Imaging in Differentiation between the Viable and Necrotic Parts of Head and Neck Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1718-4

18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

21 January 2018

1 reference

12 December 2020

Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging

1 reference

12 December 2020

2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience

1 reference

12 December 2020

18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation

1 reference

12 December 2020

[The value of diffusion-weighted MRT in assessing the bone marrow changes in vertebral metastases]

1 reference

12 December 2020

Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display

1 reference

12 December 2020

Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization

1 reference

12 December 2020

Evaluating tumors and tumorlike lesions of the nasal cavity, the paranasal sinuses, and the adjacent skull base with diffusion-weighted MRI

1 reference

12 December 2020

Quantitative Assessment of Diffusion-Weighted MR Imaging in Patients with Primary Rectal Cancer: Correlation with FDG-PET/CT

1 reference

12 December 2020

Tumor detection by diffusion-weighted MRI and ADC-mapping--initial clinical experiences in comparison to PET-CT

1 reference

12 December 2020

FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.

1 reference

12 December 2020

Vertebral metastases: assessment with apparent diffusion coefficient

1 reference

12 December 2020

Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma

1 reference

12 December 2020

Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity

1 reference

12 December 2020

Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging

1 reference

12 December 2020

Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience

1 reference

12 December 2020

Why most PET of lung and head-and-neck cancer will be PET/CT.

1 reference

12 December 2020

Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes

1 reference

12 December 2020

Diffusion-weighted magnetic resonance imaging of head and neck squamous cell carcinomas

1 reference

12 December 2020

Diffusion-weighted MR imaging (DWI) in the evaluation of epidural spinal lesions

1 reference

12 December 2020